Clinical Trials Browser

Phase 2 × Lung Neoplasms × HM781-36B × Clear all

NCT05045404 2023-09-13

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms